Estimation of Long‐Term Efficacy of Denosumab Treatment in Postmenopausal Women With Osteoporosis: A FRAX‐ and Virtual Twin‐Based Post Hoc Analysis From the FREEDOM and FREEDOM Extension Trials

The 3‐year placebo‐controlled FREEDOM (Fracture REduction Evaluation of Denosumab in Osteoporosis Every 6 Months) trial established the antifracture efficacy of denosumab in postmenopausal women with osteoporosis. The 7‐year open‐label extension demonstrated that denosumab treatment for up to 10 yea...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:JBMR Plus
Main Authors: Siris, Ethel, McDermott, Michele, Pannacciulli, Nicola, Miller, Paul D, Lewiecki, E Michael, Chapurlat, Roland, Jódar‐Gimeno, Esteban, Huang, Shuang, Kanis, John A
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2020
Teme:
Short Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7117843/
https://ncbi.nlm.nih.gov/pubmed/32258966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10348
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki